Hims & Hers Health Inc (HIMS) Stock Price & News

HomeHIMS • NYSE

Hims & Hers Health Inc

$40.68

After Hours:

$40.90

(0.54%)+0.22

Closed: Mar 3, 4:18:11 PM GMT-5 · USD · NYSE · Disclaimer

Previous close

$45.09

Day range

$39.66 - $46.35

Year range

$11.20 - $72.98

Market cap

8.89B USD

Avg Volume

26.22M

P/E ratio

76.43

Dividend yield

Primary exchange

NYSE

Top news

Investor's Business Daily

The Spectacular Dive That Saw Hims Stock Lose 45% Over Five Days

3 days ago

Yahoo Finance

Hims & Hers Health (NYSE:HIMS) Jumps 40% After Projecting US$2.3 Billion Revenue for 2025

3 hours ago

Seeking Alpha

Hims & Hers: A Generational Dip-Buying Opportunity

1 day ago

Quartz

Eli Lilly's big investment, cheaper Zepbound, and what's next for Hims & Hers: Pharma news roundup

3 days ago

Q4 earnings report for Hims

CNBC

Hims & Hers shares plunge 22% on concerns over weight loss business, margins

6 days ago

Sherwood News

Hims & Hers investors run for the hills despite earnings beat and cheery outlook

6 days ago

Barron's

Why Hims & Hers Stock Is Falling After Beating Quarterly Earnings Expectations

6 days ago

Seeking Alpha

Hims stock tumbles 20% following Q4 report, 2025 guidance (HIMS:NYSE)

6 days ago

Insider Monkey

2 days ago

Wall Street Optimism Spills Over to These 10 Stocks on Friday

The Motley Fool

2 days ago

Hims & Hers Stocks Sinks Despite Huge Revenue Growth. Is This a Buying Opportunity in the Stock?

WSJ

3 weeks ago

Hims Super Bowl Ad Spotlights Weight-Loss Drug Copycats as Clock Ticks on Their Business

SFGATE

3 weeks ago

SF company airs controversial Super Bowl ad despite multiple objections

Financials

Income Statement

Revenue

Net income

(USD)	Dec 2024	Y/Y change
Revenue	481.14M	95.09%
Operating expense	346.97M	72.24%
Net income	26.02M	1,990.36%
Net profit margin	5.41	982.00%
Earnings per share	0.23	332.44%
EBITDA	28.64M	442.97%
Effective tax rate	-16.75%	—

Balance Sheet

Total assets

Total liabilities

(USD)	Dec 2024	Y/Y change
Cash and short-term investments	300.25M	35.87%
Total assets	707.54M	60.37%
Total liabilities	230.82M	137.58%
Total equity	476.72M	—
Shares outstanding	222.17M	—
Price to book	20.88	—
Return on assets	8.62%	—
Return on capital	12.01%	—

Cash Flow

Net change in cash

(USD)	Dec 2024	Y/Y change
Net income	26.02M	1,990.36%
Cash from operations	86.38M	292.96%
Cash from investing	-17.21M	-183.14%
Cash from financing	-13.65M	-244.49%
Net change in cash	55.07M	42.41%
Free cash flow	62.98M	467.02%

About

Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products. Hims & Hers operates with a direct-to-consumer model. Consumers consult licensed healthcare professionals and access treatments and products through the company's platform. Customers pay for a consultation with a doctor to prescribe the drug along with the price of the drug itself. The company has expanded its offerings to include health solutions for both men and women, along with mental health services. Wikipedia

Founded

Nov 2017

Headquarters

San Francisco, California
United States

Website

forhims.com

Employees

1,637